|
1
|
Susceptibility of influenza A viruses to amantadine is influenced by the gene coding for M protein.
|
J Virol
|
1978
|
1.99
|
|
2
|
Topological mapping antigenic sites on the influenza A/PR/8/34 virus hemagglutinin using monoclonal antibodies.
|
Virology
|
1981
|
1.87
|
|
3
|
Human macrophages armed with murine immunoglobulin G2a antibodies to tumors destroy human cancer cells.
|
Science
|
1983
|
1.78
|
|
4
|
Antigenic variants of influenza viruses: marked differences in the frequencies of variants selected with different monoclonal antibodies.
|
Virology
|
1980
|
1.59
|
|
5
|
Nonrandom association of parental genes in influenza A virus recombinants.
|
Virology
|
1979
|
1.55
|
|
6
|
Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamsters.
|
Proc Natl Acad Sci U S A
|
1987
|
1.31
|
|
7
|
Adenovirus-associated virus structural protein sequence homology.
|
J Gen Virol
|
1979
|
1.27
|
|
8
|
The interaction of murine IgG subclass proteins with human monocyte Fc receptors.
|
J Immunol
|
1985
|
1.21
|
|
9
|
Adenovirus-human immunodeficiency virus (HIV) envelope recombinant vaccines elicit high-titered HIV-neutralizing antibodies in the dog model.
|
Proc Natl Acad Sci U S A
|
1992
|
1.15
|
|
10
|
Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogs.
|
Vaccine
|
1991
|
1.03
|
|
11
|
Isolation and characterization of anti-monosialoganglioside monoclonal antibody 19-9 class-switch variants.
|
Proc Natl Acad Sci U S A
|
1985
|
1.02
|
|
12
|
Adenovirus vectors for gene expression.
|
Curr Opin Biotechnol
|
1991
|
0.98
|
|
13
|
Induction of mouse IgG2a- and IgG3-dependent cellular cytotoxicity in human monocytic cells (U937) by immune interferon.
|
Cancer Res
|
1984
|
0.95
|
|
14
|
Adenovirus vaccine vectors expressing hepatitis B surface antigen: importance of regulatory elements in the adenovirus major late intron.
|
Virology
|
1990
|
0.95
|
|
15
|
A new hamster model for adenoviral vaccination.
|
Arch Virol
|
1988
|
0.95
|
|
16
|
High level expression of the envelope glycoproteins of the human immunodeficiency virus type I in presence of rev gene using helper-independent adenovirus type 7 recombinants.
|
Virology
|
1990
|
0.94
|
|
17
|
Immunogenicity of recombinant adenovirus-respiratory syncytial virus vaccines with adenovirus types 4, 5, and 7 vectors in dogs and a chimpanzee.
|
J Infect Dis
|
1992
|
0.93
|
|
18
|
Adenovirus vectored vaccines.
|
Dev Biol Stand
|
1994
|
0.92
|
|
19
|
Initial safety and immunogenicity studies of an oral recombinant adenohepatitis B vaccine.
|
Vaccine
|
1992
|
0.91
|
|
20
|
Monoclonal antibody-defined correlations in melanoma between levels of GD2 and GD3 antigens and antibody-mediated cytotoxicity.
|
Cancer Res
|
1987
|
0.91
|
|
21
|
Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptor.
|
Mol Pharmacol
|
1993
|
0.90
|
|
22
|
Immunogenicity of recombinant human adenovirus-human immunodeficiency virus vaccines in chimpanzees.
|
AIDS Res Hum Retroviruses
|
1993
|
0.90
|
|
23
|
Efficacy of adenovirus-vectored respiratory syncytial virus vaccines in a new ferret model.
|
Vaccine
|
1994
|
0.86
|
|
24
|
Enhanced immunogenicity of hepatitis B surface antigen by insertion of a helper T cell epitope from tetanus toxoid.
|
Vaccine
|
1999
|
0.86
|
|
25
|
Current use and future directions of adenovirus vaccine.
|
Semin Respir Infect
|
1989
|
0.85
|
|
26
|
Co-expression of hepatitis B virus antigens by a non-defective adenovirus vaccine vector.
|
Arch Virol
|
1991
|
0.82
|
|
27
|
Tumor cell lysis and tumor growth inhibition by the isotype variants of MAb BR55-2 directed against Y oligosaccharide.
|
In Vivo
|
1992
|
0.81
|
|
28
|
Immunogenicity of high expression adenovirus-hepatitis B virus recombinant vaccines in dogs.
|
J Gen Virol
|
1994
|
0.81
|
|
29
|
Helper independent recombinant adenovirus vectors: expression of HIV env or HBV surface antigen.
|
Int Rev Immunol
|
1990
|
0.80
|
|
30
|
Radioiodination of adenovirus-associated virus external structural proteins.
|
Virology
|
1977
|
0.79
|
|
31
|
Replication and immunogenicity of Ad7-, Ad4-, and Ad5-hepatitis B virus surface antigen recombinants, with or without a portion of E3 region, in chimpanzees.
|
Vaccine
|
1997
|
0.79
|
|
32
|
Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virus.
|
Vaccine
|
1995
|
0.79
|
|
33
|
Multiplication of bovine parvovirus in two cell strains.
|
Infect Immun
|
1976
|
0.77
|
|
34
|
Expression of HBV surface antigen or HIV envelope protein using recombinant adenovirus vectors.
|
Nat Immun Cell Growth Regul
|
1988
|
0.75
|